News & Events
Philogen S.p.A announced the launch of a pivotal trial in patients with Stage IIIB/C melanoma, following promising results obtained in a Phase II study with an innovative immunotherapeutic approach. Siena, 21st January 2016.
Last News & Events
No Results Found
The posts you requested could not be found. Try changing your module settings or create some new posts.